Back to Search
Start Over
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes:an individual patient data meta-analysis
- Source :
- Petroff, D, Blank, V, Newsome, P N, Shalimar, Voican, C S, Thiele, M, de Lédinghen, V, Baumeler, S, Chan, W K, Perlemuter, G, Cardoso, A-C, Aggarwal, S, Sasso, M, Eddowes, P J, Allison, M, Tsochatzis, E, Anstee, Q M, Sheridan, D, Cobbold, J F, Naveau, S, Lupsor-Platon, M, Mueller, S, Krag, A, Irles-Depe, M, Semela, D, Wong, G L-H, Wong, V W-S, Villela-Nogueira, C A, Garg, H, Chazouillères, O, Wiegand, J & Karlas, T 2021, ' Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes : an individual patient data meta-analysis ', The Lancet Gastroenterology & Hepatology, vol. 6, no. 3, pp. 185-198 . https://doi.org/10.1016/S2468-1253(20)30357-5
- Publication Year :
- 2021
-
Abstract
- BACKGROUND: Diagnostic tools for liver disease can now include estimation of the grade of hepatic steatosis (S0 to S3). Controlled attenuation parameter (CAP) is a non-invasive method for assessing hepatic steatosis that has become available for patients who are obese (FibroScan XL probe), but a consensus has not yet been reached regarding cutoffs and its diagnostic performance. We aimed to assess diagnostic properties and identify relevant covariates with use of an individual patient data meta-analysis.METHODS: We did an individual patient data meta-analysis, in which we searched PubMed and Web of Science for studies published from database inception until April 30, 2019. Studies reporting original biopsy-controlled data of CAP for non-invasive grading of steatosis were eligible. Probe recommendation was based on automated selection, manual assessment of skin-to-liver-capsule distance, and a body-mass index (BMI) criterion. Receiver operating characteristic methods and mixed models were used to assess diagnostic properties and covariates. Patients with non-alcoholic fatty liver disease (NAFLD) were analysed separately because they are the predominant patient group when using the XL probe. This study is registered with PROSPERO, CRD42018099284.FINDINGS: 16 studies reported histology-controlled CAP including the XL probe, and individual data from 13 papers and 2346 patients were included. Patients with a mean age of 46·5 years (SD 14·5) were recruited from 20 centres in nine countries. 2283 patients had data for BMI; 673 (29%) were normal weight (BMI INTERPRETATION: CAP cutoffs varied according to cause, and can effectively recognise significant steatosis in patients with viral hepatitis. CAP cannot grade steatosis in patients with NAFLD adequately, but its value in a NAFLD screening setting needs to be studied, ideally with methods beyond the traditional histological reference standard.FUNDING: The German Federal Ministry of Education and Research and Echosens.
- Subjects :
- Adult
Male
medicine.medical_specialty
Biopsy
MEDLINE
Severity of Illness Index
Body Mass Index
03 medical and health sciences
Liver disease
0302 clinical medicine
Non-alcoholic Fatty Liver Disease
Internal medicine
Severity of illness
medicine
Humans
Hepatology
Receiver operating characteristic
business.industry
Fatty liver
Gastroenterology
Middle Aged
medicine.disease
3. Good health
Liver
ROC Curve
030220 oncology & carcinogenesis
Meta-analysis
Area Under Curve
Elasticity Imaging Techniques
030211 gastroenterology & hepatology
Female
Steatosis
business
Body mass index
Subjects
Details
- Language :
- English
- ISSN :
- 42018099
- Database :
- OpenAIRE
- Journal :
- Petroff, D, Blank, V, Newsome, P N, Shalimar, Voican, C S, Thiele, M, de Lédinghen, V, Baumeler, S, Chan, W K, Perlemuter, G, Cardoso, A-C, Aggarwal, S, Sasso, M, Eddowes, P J, Allison, M, Tsochatzis, E, Anstee, Q M, Sheridan, D, Cobbold, J F, Naveau, S, Lupsor-Platon, M, Mueller, S, Krag, A, Irles-Depe, M, Semela, D, Wong, G L-H, Wong, V W-S, Villela-Nogueira, C A, Garg, H, Chazouillères, O, Wiegand, J & Karlas, T 2021, ' Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes : an individual patient data meta-analysis ', The Lancet Gastroenterology & Hepatology, vol. 6, no. 3, pp. 185-198 . https://doi.org/10.1016/S2468-1253(20)30357-5
- Accession number :
- edsair.doi.dedup.....cfc8a57f77278c1c2dc69e657e3b3a3b
- Full Text :
- https://doi.org/10.1016/S2468-1253(20)30357-5